Trial Profile
The effectiveness of peginterferon -alpha2a and the entecavir combination therapy for the chronic hepatitis B patient
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2021
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 30 Jul 2021 Status changed from recruiting to completed.
- 21 Jan 2015 New trial record